Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2004-01-16
2011-10-11
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000
Reexamination Certificate
active
08034798
ABSTRACT:
The invention relates to a novel use of derivatives of neurosteroids, particularly pregnenolone, for the treatment of acute or chronic lesions of the nervous system, especially certain neurodegenerative diseases, related in particular to the ability thereof to stabilize and/or increase the polymerization of neuronal microtubules.
REFERENCES:
patent: 6245757 (2001-06-01), Chopp et al.
patent: 2002/0072509 (2002-06-01), Stein et al.
patent: 1 310 258 (2003-05-01), None
patent: 1310258 (2003-05-01), None
patent: WO 01/68068 (2001-09-01), None
patent: WO 02/36128 (2002-05-01), None
MedlinePlus Medical Encyclopedia: Multiple Sclerosis, retrieved on Mar. 28, 2008 via www.nlm.nih.gov/medlineplus/ency/article/000737.htm, dated on Aug. 6, 2007, p. 1 and 2.
MedlinePlus Medical Encyclopedia: Multiple Sclerosis, retrieved on Mar. 28, 2008, p. 2; also see WebMD: Multiple Sclerosis—Prevention, retrieved on Mar. 28, 2008 via www.webmd.com/multiple-sclerosis/tc/multiple-sclerosis-ms-prevention, dated on Mar. 23, 2006.
The Merck Index (Twelfth Edition, 1996: p. 1328, compound 7915).
Chemical Book (retrieved via www.chemicalbook.com for the structure of pregnenolone methyl ether), retrieved on Apr. 30, 2009.
Merriam-Webster Online Dictionary: the Definition of Drug (www.merriam-webster.com), retrieved on Apr. 30, 2009.
Kolb et al., Nerve Growth Factor Treatment Prevents Dendritic Atrophy and Promotes Recovery of Function After Cortical Injury, Neuroscience, vol. 76, No. 4, pp. 1139-1151, (1996).
Zhang et al., “Cytoskeletal Disruption Following Contusion Injury to the Rat Spinal Cord”, Journal of Neuropathology and Experimental Neurology, vol. 59, No. 4, pp. 287-296, (2000).
Schumacher et al., “Pretreatment with Calpain Inhibitor CPE-4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord Injury”, Journal of Neurochemistry, vol. 74, No. 4, pp. 1646-1655, (2000).
Springer et al., “Rapid Calpain I Activation and Cytoskeletal Protein Degradation Following Traumatic Spinal Cord Injury: Attenuation with Riluzole Pretreatment”, Journal of Neurochemistry, vol. 69, No. 4, pp. 1592-1600, (1997).
Matus, “MAP2”, Microtubules, pp. 155-166, (1994).
Sánchez et al., “Phosphorylation of Microtubule-Associated Protein 2 (MAP2) and its Relevance for the Regulation of the Neuronal Cytoskeleton Function”, Progress in Neurobiology, vol. 61, pp. 133-168, (2000).
Caceres, et al., “Suppression of MAP2 in Cultured Cerebeller Macroneurons Inhibits Minor Neurite Formation”, Neuron, vol. 9, pp. 607-618, (1992).
Harada et al., “MAP2 is Required for Dendrite Elongation, PKA Anchoring in Dendrites, and Proper PKA Signal Transduction”, The Journal of Cell Biology, vol. 158, No. 3, pp. 541-549, (2002).
Reyna-Neyra et al., “Estradiol and Progesterone Modify Microtubule Associated Protein 2 Content in the Rat Hippocampus”, Brain Research Bulletin, vol. 58, No. 6, pp. 607-612, (2002).
Nakatomi et al., “Regeneration of Hippocampal Pyramidal Neurons after Ischemic Brain Injury by Recruitment of Endogenous Neural Progenitors”, Cell, vol. 110, pp. 429-441, (2002).
García-Estrada et al., “Dehydroepiandrosterone, Pregnenolone and Sex Steroids Down-Regulate Reactive Astroglia in the Male Rat Brain after a Penetrating Brain Injury”, Int. J. Devl. Neuroscience, vol. 17, No. 2, pp. 145-150, (1999).
Legrand et al., “Pregnenolone Reverses the Age-Dependent Accumulation of Glial Fibrillary Acidic Protein within Astrocytes of Specific Regions of the Rat Brain”, Brain Research, vol. 802, pp. 125-132, (1998).
Guth et al., “Key Role for Pregnenolone in Combination Therapy that Promotes Recovery after Spinal Cord Injury”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 12308-12311, (1994).
Gursoy et al., “Pregnenolone Protects Mouse Hippocampal (HT-22) Cells Against Glutamate and Amyloid Beta Protein Toxicity”, Neurochemical Research, vol. 26, No. 1, pp. 15-21, (2001).
Murakami et al., “Pregnenolone Binds to Microtubule-Associated Protein 2 and Stimulates Microtubule Assembly”, PNAS, vol. 97, No. 7, pp. 3579-3584, (2000).
Baulieu Etienne-Emile
Fellous Esther
Robel Paul
Chui Mei-Ping
Finnegan Henderson Farabow Garrett & Dunner LLP
MAPREG
Richter Johann
LandOfFree
Use of 3-methoxy-pregnenolone in the production of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3-methoxy-pregnenolone in the production of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-methoxy-pregnenolone in the production of a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269673